Proposed Permanent Rules: In Promulgation Process
Relating to scheduling 2 synthetic benzimidazole-opioids.
Relating to scheduling 2-methyl AP-237.
Relating to scheduling ADB-BUTINACA, a-PiHP, and 3-MMC.
Relating to scheduling five synthetic cannabinoids.
Relating to mail delivered prescriptions.
Relating to scheduling nine fentanyl-related substances.
Relating to scheduling Zuranolone.
Relating to transferring Flualprazolam and scheduling four (4) synthetic benzodiazepine substances.
Relating to monitored prescription drug history reports.
Relating to excluding Fenfluramine.
Relating to scheduling Methiopropamine.
Relating to national provider identifier requirement.
Relating to scheduling Mesocarb.
Relating to excluding [18 F]FP-CIT.
/code/chr/active